Alzheimer's disease: Channeling APP to non-amyloidogenic processing

Biochemical and Biophysical Research Communications

Volumn 331, Issue 2, 2005, Pages 375-378

  Tang, Bor Luen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Alzheimer's disease; Non steroidal anti inflammatory drugs; Rho; Rho associated protein kinase; Statins; Amyloid

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; AMYLOID; AMYLOID PRECURSOR PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; ISOPRENOID; MEVALONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC SULFIDE;

ALZHEIMER DISEASE; CALORIC INTAKE; CALORIC RESTRICTION; CELL CULTURE; DIETARY INTAKE; DISEASE COURSE; DRUG EFFECT; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; METABOLIC DISORDER; MICROGLIA; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SENILE PLAQUE; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

EID: 18044398037     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.03.074     Document Type: Short Survey

References (34)

1. V. Wilquet, and B. De Strooper Amyloid-beta precursor protein processing in neurodegeneration Curr. Opin. Neurobiol. 14 2004 582 588
2. T.M. Allinson, E.T. Parkin, A.J. Turner, and N.M. Hooper ADAMs family members as amyloid precursor protein α-secretases J. Neurosci. Res. 74 2003 342 352
3. M.P. Mattson Secreted forms of beta-amyloid precursor protein modulate dendritic outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons J. Neurobiol. 25 1994 439 450
4. H. Meziane, J.C. Dodart, C. Mathis, S. Little, J. Clemens, S.M. Paul, and A. Ungerer Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice Proc. Natl. Acad. Sci. USA 95 1998 12683 12688
5. J.J. Hoozemans, R. Veerhuis, A.J. Rozemuller, and P. Eikelenboom Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease Curr. Drug Targets 4 2003 461 468
6. C.A. Szekely, J.E. Thorne, P.P. Zandi, M. Ek, E. Messias, J.C. Breitner, and S.N. Goodman Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review Neuroepidemiology 23 2004 159 169
7. S. Parvathy, M. Ehrlich, S. Pedrini, N. Diaz, L. Refolo, J.D. Buxbaum, A. Bogush, S. Petanceska, and S. Gandy Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding J. Neurochem. 90 2004 1005 1010
8. S. Pedrini, T.L. Carter, G. Prendergast, S. Petanceska, M.E. Ehrlich, and S. Gandy Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK PLoS Med. 2 2005 e18
9. Y. Levites, T. Amit, S. Mandel, and M.B. Youdim Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3- gallate FASEB J. 17 2003 952 954
10. F. Colciaghi, B. Borroni, M. Zimmermann, C. Bellone, A. Longhi, A. Padovani, F. Cattabeni, Y. Christen, and M. Di Luca Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts Neurobiol. Dis. 16 2004 454 460
11. J. Wang, L. Ho, W. Qin, R.B. Rocher, I. Seror, N. Humala, K. Maniar, G. Dolios, R. Wang, P.R. Hof, G.M. Pasinetti, Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J. (in press) (online 13 Jan 2005; 10.1096/fj.04-3182fje)
12. 42 in vivo J. Clin. Invest. 112 2003 440 449
13. S. Weggen, J.L. Eriksen, S.A. Sagi, C.U. Pietrzik, V. Ozols, A. Fauq, T.E. Golde, and E.H. Koo Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid β42 production by direct modulation of γ-secretase activity J. Biol. Chem. 278 2003 31831 31837
14. Y. Avramovich, T. Amit, and M.B. Youdim Non-steroidal anti-inflammatory drugs stimulate secretion of non-amyloidogenic precursor protein J. Biol. Chem. 277 2002 31466 31473
15. Y. Zhou, Y. Su, B. Li, F. Liu, J.W. Ryder, X. Wu, P.A. Gonzalez-DeWhitt, V. Gelfanova, J.E. Hale, P.C. May, S.M. Paul, and B. Ni Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho Science 302 2003 1215 1217
16. W.J. Streit Microglia and Alzheimer's disease pathogenesis J. Neurosci. Res. 77 2004 1 8
17. W.J. Streit, R.E. Mrak, and W.S. Griffin Microglia and neuroinflammation: a pathological perspective J. Neuroinflamm. 1 2004 14
18. A. Cordal, and G. Landreth 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate beta-amyloid-induced microglial inflammatory responses J. Neurosci. 25 2005 299 307
19. G. Li, R. Higdon, W.A. Kukull, E. Peskind, K. Van Valen Moore, D. Tsuang, G. Van Belle, W. McCormick, J.D. Bowen, L. Teri, G.D. Schellenberg, and E.B. Larson Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study Neurology 63 2004 1624 1628
20. X. Bi, M. Baudry, J. Liu, Y. Yao, L. Fu, F. Brucher, and G. Lynch Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3- methylglutaryl (HMG)-CoA reductase inhibitors on microglia J. Biol. Chem. 279 2004 48238 48245
21. V. Meske, F. Albert, D. Richter, J. Schwarze, and T.G. Ohm Blockade of HMG-CoA reductase activity causes changes in microtubule-stabilizing protein tau via suppression of geranylgeranylpyrophosphate formation: implications for Alzheimer's disease Eur. J. Neurosci. 17 2003 93 102
22. J.A. Luchsinger, M.X. Tang, S. Shea, and R. Mayeux Caloric intake and the risk of Alzheimer's disease Arch. Neurol. 59 2002 1258 1263
23. M.P. Mattson, S.L. Chan, and W. Duan Modification of brain aging and neurodegenerative disorders by genes, diet and behavior Physiol. Rev. 82 2002 637 672
24. L. Ho, W. Qin, P.N. Pompl, Z. Xiang, J. Wang, Z. Zhao, Y. Peng, G. Cambareri, A. Rocher, C.V. Mobbs, P.R. Hof, and G.M. Pasinetti Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease FASEB J. 18 2004 902 904
25. N. Rasgon, and L. Jarvik Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis J. Gerontol. A: Biol. Sci. Med. Sci. 59 2004 178 183
26. W. Farris, S. Mansourian, M.A. Leissring, E.A. Eckman, L. Bertram, C.B. Eckman, R.E. Tanzi, and D.J. Selkoe Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein Am. J. Pathol. 164 2004 1425 1434
27. S.D. Hursting, J.A. Lavigne, D. Berrigan, S.N. Perkins, and J.C. Barrett Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans Annu. Rev. Med. 54 2003 131 152
28. J. Koubova, and L. Guarente How does calorie restriction work? Genes Dev. 17 2003 313 321
29. J. Smith Human Sir2 and the 'silencing' of p53 activity Trends. Cell Biol. 12 2002 404 406
30. F. Yeung, J.E. Hoberg, C.S. Ramsey, M.D. Keller, D.R. Jones, R.A. Frye, and M.W. Mayo Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase EMBO J. 23 2004 2369 2380
31. A. Antebi Tipping the balance toward longevity Dev. Cell 6 2004 315 316
32. F. Picard, M. Kurtev, N. Chung, A. Topark-Ngarm, T. Senawong, R. Machado De Oliveira, M. Leid, M.W. McBurney, and L. Guarente Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma Nature 429 2004 771 776
33. T. Araki, Y. Sasaki, and J. Milbrandt Increase nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration Science 305 2004 1010 1013
34. R. Postina, A. Schroeder, I. Dewachter, J. Bohl, U. Schmitt, E. Kojro, C. Prinzen, K. Endres, C. Hiemke, M. Blessing, P. Flamez, A. Dequenne, E. Godaux, F. van Leuven, and F. Fahrenholz A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model J. Clin. Invest. 113 2004 1456 1464